a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:February 8, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:February 8, 2024Recruiting
Condition(s):Oral Surgical Procedures; Surgery, Oral; Mandibular ReconstructionLast Updated:December 12, 2023Enrolling by invitation
Condition(s):Nerve Injury; Peripheral Nerve InjuriesLast Updated:March 15, 2024Recruiting
Condition(s):Lung Transplant Failure; Lung Transplant; ComplicationsLast Updated:September 18, 2023Recruiting
Condition(s):Head and Neck Neoplasms; Osteoradionecrosis; Radiotherapy; ComplicationsLast Updated:June 9, 2022Unknown status
Condition(s):Lung Cancer; Non-small Cell Lung Cancer; Lung Adenocarcinoma; Squamous Cell Lung CancerLast Updated:May 27, 2022Recruiting
Condition(s):Neuroendocrine TumorsLast Updated:March 8, 2024Active, not recruiting
Condition(s):Lung Transplant Rejection; Primary Graft Dysfunction; Chronic Rejection of Lung TransplantLast Updated:May 16, 2022Recruiting
Condition(s):Lung Transplant Failure; Lung Transplant; ComplicationsLast Updated:September 8, 2023Completed
Condition(s):Liver Metastases; Liver Cancer; Postoperative Pain; Opioid UseLast Updated:December 10, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.